Navigation Links
CellHealth Institute is Named 2013 Edison Award Winner
Date:5/9/2013

MONTCLAIR, N.J. (PRWEB) May 09, 2013

CellHealth™ Institute was voted a bronze winner for innovation at the Edison Awards. The event, celebrating 26 years of honoring the best in innovation and excellence in the development of new products and services, took place on April 25th event at Navy Pier in Chicago. Dr. Vincent Giampapa, CellHealth Institute’s founder and chief medical officer, joined hundreds of senior executives from some of the world’s most recognized companies to acknowledge the hard work and commitment of all of the 2013 Edison Award winners.

CellHealth Institute, a biotechnology company focused on cellular health that combines products and services with holistic lifestyle education, was awarded for its innovative health and wellness services. Dr. Vincent Giampapa also spoke about personalized cell health and CHI’s new cell health formula, everycell™, at the ‘Meet The Innovators’ Forum.

“We’re delighted that our innovations in cell health are gaining strong support in such illustrious circles,” said Dr. Vincent Giampapa.

“Our judges recognized CellHealth Institute as a true innovator out of the many products in health and wellness,” said Frank Bonafilia, executive director of the Edison Awards.

The ballot of nominees for the Edison Awards™ was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medical.

One of the evening’s many highlights was the presentation of the Edison Achievement Award to Dr. Paul E. Jacobs, chairman and CEO of Qualcomm Incorporated. The award honors innovation leaders and business executives who have made a significant and lasting contribution to innovation throughout their careers.

About CellHealth™ Institute
CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10716610.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CellHealth Institute Launches New Cell Health Formula
2. CellHealth Institute Launches with Support from Influential Investors
3. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
4. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
5. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
6. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
7. Stem Cell Institute Public Seminar on Adult Stem Cell Therapy in Miami, Florida May 11th, 2013
8. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
9. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
10. California Healthcare Institute Announces Executive Promotion
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
Breaking Biology Technology:
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
(Date:1/20/2016)... 20, 2016 A market that just keeps ... from the explosion in genomics knowledge. Learn all about ... A range of dynamic trends are pushing market growth ... medicine - pharmacogenomics - pathogen evolution - next generation ... - greater understanding of the role of genetic material ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., a ... simplifies the use and access of ubiquitous on-premise ... partnership with American Cyber.  ... experience leading transformational C4ISR and Cyber initiatives in ... the latest proven technology solutions," said Steve ...
Breaking Biology News(10 mins):